In this context, pRKIP could constitute an early surrogate marker potentially useful for the early diagnosis of ccRCC as it allows for identification of the early stages of neoplastic transformation that correlate with the initial downregulation of RKIP. Here, PEBP1 is linked to nonpapillary renal cell carcinoma.